8-K

Company

10x Genomics, Inc.

Filed

January 12, 2026

Period of Report

January 11, 2026

Accession Number

0001628280-26-001808

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →